Skip to main content

Table 1 The relationship between miR-29a-3p expression in EC tissues and clinicopathological characteristics of patients

From: miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1

Characteristics Number(n = 72) Relative miR-29a-3p expression P value
Age (years)    0.2910
  < 50 36 0.533 ± 0.107  
  ≥ 50 36 0.504 ± 0.132  
Differentiation    0.001**
 High and mediumdifferentiation 31 0.587 ± 0.106  
 Low and undifferentiation 41 0.467 ± 0.102  
FIGO stage    < 0.0001 ***
 I-II 43 0.566 ± 0.098  
 III-IV 29 0.448 ± 0.116  
Cancer type    0.9093
 Type I 24 0.516 ± 0.131  
 Type II 48 0.520 ± 0.116  
Muscular infiltration    0.0002 ***
  < 1/2 34 0.572 ± 0.103  
  ≥ 1/2 38 0.471 ± 0.115  
Lymphatic metastasis    < 0.0001 ***
 No 28 0.548 ± 0.124  
 Yes 44 0.423 ± 0.115  
  1. **P < 0.01 and ***P < 0.001. Note: Type I indicated patientswithestrogen receptor-dependent EC. Type II indicated patients with non-estrogen receptor-dependent EC